AHG
Financial ServicesAkso Health Group · Financial - Credit Services · $210M
AHG — Key Takeaways
✅ Strengths
⚠️ Areas of Concern
AHG — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | 28.1 | 8.7 | 8.0 | 81.3 | 51.3 | 0.0 | 0.0 |
| Apr 7, 2026 | 28.1 | 8.8 | 8.0 | 81.3 | 51.3 | 0.0 | +0.8 |
| Apr 6, 2026 | 27.3 | 5.2 | 8.0 | 81.3 | 51.3 | 0.0 | 0.0 |
| Apr 5, 2026 | 27.3 | 5.2 | 8.0 | 81.3 | 51.3 | 0.0 | 0.0 |
| Apr 4, 2026 | 27.3 | 5.2 | 8.0 | 81.3 | 51.3 | 0.0 | 0.0 |
| Apr 3, 2026 | 27.3 | 5.2 | 8.0 | 81.3 | 51.3 | 0.0 | +0.1 |
| Apr 2, 2026 | 27.2 | 5.0 | 8.0 | 81.3 | 51.3 | 0.0 | — |
AHG — Pillar Breakdown
Quality
— 8.7/100 (25%)Akso Health Group currently shows below-average quality metrics, suggesting challenges with profitability.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Free cash flow relative to market value.
Growth
— 81.3/100 (20%)Akso Health Group is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Risk
— 51.3/100 (15%)Akso Health Group has some risk factors including moderate leverage or solvency concerns.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 0.0/100 (15%)Akso Health Group appears expensively valued relative to its fundamentals and growth prospects.
Moat
— 8/100 (30%)Akso Health Group operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for AHG.
Score Composition
More Stock Analysis
How is the AHG UQS Score Calculated?
The UQS (Unified Quality Score) for Akso Health Group is calculated using a proprietary 5-pillar framework with 25 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Akso Health Group's competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Akso Health Group is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.